EFNB2 and neoplasm: Concordant with our previous data, EFNB2-Fc, EFNB2-Fc-His, and Fc-TNYL-RAW-GS all significantly reduced local tumor growth while EFNB2-Fc-His was the only treatment that yielded a significant improvement in overall survival (Figure 7B-D).